Seamus Fernandez

Stock Analyst at Guggenheim

(4.17)
# 439
Out of 4,893 analysts
103
Total ratings
54.17%
Success rate
13.96%
Average return

Stocks Rated by Seamus Fernandez

Apogee Therapeutics
Jul 2, 2025
Reiterates: Buy
Price Target: $116
Current: $38.57
Upside: +200.75%
Cidara Therapeutics
Jun 24, 2025
Maintains: Buy
Price Target: $50$68
Current: $50.88
Upside: +33.65%
Amylyx Pharmaceuticals
Jun 24, 2025
Initiates: Buy
Price Target: $17
Current: $7.39
Upside: +130.04%
Eli Lilly and Company
Jun 20, 2025
Reiterates: Buy
Price Target: $936
Current: $790.65
Upside: +18.38%
MBX Biosciences
Apr 10, 2025
Reiterates: Buy
Price Target: $44
Current: $12.39
Upside: +255.13%
Arcutis Biotherapeutics
Apr 3, 2025
Reiterates: Buy
Price Target: n/a
Current: $15.27
Upside: -
Verve Therapeutics
Mar 25, 2025
Reiterates: Buy
Price Target: n/a
Current: $11.06
Upside: -
Vaxcyte
Mar 12, 2025
Reiterates: Buy
Price Target: $160
Current: $36.26
Upside: +341.26%
Metsera
Feb 25, 2025
Initiates: Buy
Price Target: $56
Current: $36.41
Upside: +53.80%
Mineralys Therapeutics
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $14.63
Upside: -
Maintains: Buy
Price Target: $137$130
Current: $84.02
Upside: +54.73%
Downgrades: Neutral
Price Target: n/a
Current: $39.58
Upside: -
Initiates: Buy
Price Target: $70
Current: $89.04
Upside: -21.38%
Initiates: Buy
Price Target: $16
Current: $5.82
Upside: +174.91%
Downgrades: Neutral
Price Target: n/a
Current: $2.11
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $4.40
Upside: -
Maintains: Buy
Price Target: n/a
Current: $14.48
Upside: -
Initiates: Buy
Price Target: $50
Current: $18.90
Upside: +164.55%
Downgrades: Neutral
Price Target: n/a
Current: $48.52
Upside: -
Upgrades: Buy
Price Target: n/a
Current: $71.01
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $123.73
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $7.22
Upside: -
Maintains: Outperform
Price Target: $56$54
Current: $1.59
Upside: +3,296.23%
Maintains: Market Perform
Price Target: $60$45
Current: $22.68
Upside: +98.41%
Maintains: Market Perform
Price Target: $36$38
Current: $71.81
Upside: -47.08%
Maintains: Market Perform
Price Target: $35$38
Current: $25.78
Upside: +47.40%